These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21408146)

  • 1. Quantitative interpretation of a genetic model of carcinogenesis using computer simulations.
    Dai D; Beck B; Wang X; Howk C; Li Y
    PLoS One; 2011 Mar; 6(3):e16859. PubMed ID: 21408146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling somatic evolution in tumorigenesis.
    Spencer SL; Gerety RA; Pienta KJ; Forrest S
    PLoS Comput Biol; 2006 Aug; 2(8):e108. PubMed ID: 16933983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
    Chien JR; Aletti G; Bell DA; Keeney GL; Shridhar V; Hartmann LC
    J Cell Biochem; 2007 Dec; 102(5):1117-29. PubMed ID: 17879946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is cancer really a 'local' cellular clonal disease?
    Bronchud MH
    Med Hypotheses; 2002 Nov; 59(5):560-5. PubMed ID: 12376079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model relating chromosome aberrations to cancer progression.
    DiPierdomenico J; Ying H; Lin F; Heng HH
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():2028-31. PubMed ID: 17946086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.
    Jacqueroud L; Bouard C; Richard G; Payen L; Devouassoux-Shisheboran M; Spicer DB; Caramel J; Collin G; Puisieux A; Tissier A; Ansieau S
    Neoplasia; 2016 May; 18(5):317-327. PubMed ID: 27237323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Explanation of enigmas of the Lynch syndrome thanks to a new carcinogenesis model characterized by an unorthodox initiation process].
    Janin N
    C R Acad Sci III; 1999 Dec; 322(12):1017-31. PubMed ID: 10656143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis.
    Letouzé E; Allory Y; Bollet MA; Radvanyi F; Guyon F
    Genome Biol; 2010; 11(7):R76. PubMed ID: 20649963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling a cancerous tumor development in a virtual patient suffering from a depressed state of mind: Simulation of somatic evolution with a customized genetic algorithm.
    Lahoz-Beltra R; Rodriguez RJ
    Biosystems; 2020 Dec; 198():104261. PubMed ID: 33002528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On?
    Sinjab A; Han G; Wang L; Kadara H
    Cancer Res; 2020 Nov; 80(22):4888-4891. PubMed ID: 33023945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and molecular markers of urothelial premalignancy and malignancy.
    Cordon-Cardo C; Cote RJ; Sauter G
    Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial Measures of Genetic Heterogeneity During Carcinogenesis.
    Storey K; Ryser MD; Leder K; Foo J
    Bull Math Biol; 2017 Feb; 79(2):237-276. PubMed ID: 27905065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Diversity in Normal Cell Populations is the Earliest Stage of Oncogenesis Leading to Intra-Tumor Heterogeneity.
    Howk CL; Voller Z; Beck BB; Dai D
    Front Oncol; 2013; 3():61. PubMed ID: 23577323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting Oncogenic RTK Pathways in Colorectal Cancer Initiation and Progression.
    McManus S; Chababi W; Arsenault D; Dubois CM; Saucier C
    Methods Mol Biol; 2018; 1765():27-42. PubMed ID: 29589299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignancy potential of precursor lesions: determination using molecular markers].
    Jung A
    Pathologe; 2011 Nov; 32 Suppl 2():188-94. PubMed ID: 21931996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of oncogenic cooperation in cancer initiation and metastasis.
    Pedraza-Fariña LG
    Yale J Biol Med; 2006 Dec; 79(3-4):95-103. PubMed ID: 17940619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.